136 related articles for article (PubMed ID: 29997939)
1. ypT0N+: the unusual patient with pathological complete tumor response but with residual lymph node disease after neoadjuvant chemoradiation for esophageal cancer, what's up?
Depypere LP; Vervloet G; Lerut T; Moons J; De Hertogh G; Sagaert X; Coosemans W; Van Veer H; Nafteux PR
J Thorac Dis; 2018 May; 10(5):2771-2778. PubMed ID: 29997939
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of residual nodal disease following neoadjuvant chemoradiation for esophageal cancer in patients with complete primary tumor response.
Blackham AU; Yue B; Almhanna K; Saeed N; Fontaine JP; Hoffe S; Shridhar R; Frakes J; Coppola D; Pimiento JM
J Surg Oncol; 2015 Nov; 112(6):597-602. PubMed ID: 26394724
[TBL] [Abstract][Full Text] [Related]
3. ypT0N+ status in oesophageal cancer patients: Location of residual metastatic lymph nodes with regard to the neoadjuvant radiation field.
Schurink B; Seesing MFJ; Goense L; Mook S; Brosens LAA; Mohammad NH; Ruurda JP; Roeling TAP; Bleys RLAW; van Hillegersberg R
Eur J Surg Oncol; 2019 Mar; 45(3):454-459. PubMed ID: 30503227
[TBL] [Abstract][Full Text] [Related]
4. Impact of pathological tumor response after CROSS neoadjuvant chemoradiotherapy followed by surgery on long-term outcome of esophageal cancer: a population-based study.
Al-Kaabi A; van der Post RS; van der Werf LR; Wijnhoven BPL; Rosman C; Hulshof MCCM; van Laarhoven HWM; Verhoeven RHA; Siersema PD
Acta Oncol; 2021 Apr; 60(4):497-504. PubMed ID: 33491513
[TBL] [Abstract][Full Text] [Related]
5. Prognostic role of pathologic status other than complete response after neoadjuvant therapy followed by surgery in esophageal squamous cell carcinoma.
Park SY; Lee J; Oh D; Sun JM; Yun J; Jeon YJ; Cho JH; Choi YS; Zo JI; Shim YM; Kim HK
Esophagus; 2024 Jan; 21(1):51-57. PubMed ID: 38082188
[TBL] [Abstract][Full Text] [Related]
6. Residual lymph node disease and mortality following neoadjuvant chemoradiation and curative esophagectomy for distal esophageal adenocarcinoma.
Kandilis A; Iniguez CB; Khalil H; Mazzola E; Jaklitsch MT; Swanson SJ; Bueno R; Wee JO
JTCVS Open; 2021 Mar; 5():135-147. PubMed ID: 36003158
[TBL] [Abstract][Full Text] [Related]
7. Tumor regression grade combined with lymph node status in esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy.
Yun JK; Kim Y; Lee GD; Choi S; Kim YH; Kim DK; Park SI; Kim HR
Cancer Med; 2022 Oct; 11(19):3623-3632. PubMed ID: 35434935
[TBL] [Abstract][Full Text] [Related]
8. Equivalent prognosis with no lymph node metastasis to pathological complete remission in patients with localized advanced esophageal cancer after neoadjuvant triplet chemotherapy with docetaxel, cisplatin, and 5-fluorouracil followed by curative surgery: a single-center retrospective cohort study.
Chinen T; Yamaguchi H; Ohzawa H; Matsumoto S; Kurashina K; Saito S; Hosoya Y; Fujii H; Kitayama J; Sata N
J Thorac Dis; 2024 Jan; 16(1):391-400. PubMed ID: 38410613
[TBL] [Abstract][Full Text] [Related]
9. Added value of MRI to endoscopic and endosonographic response assessment after neoadjuvant chemoradiotherapy in oesophageal cancer.
Vollenbrock SE; van Dieren JM; Voncken FEM; van Turenhout ST; Kodach LL; Hartemink KJ; van Sandick JW; Aleman BMP; Beets-Tan RGH; Bartels-Rutten A
Eur Radiol; 2020 May; 30(5):2425-2434. PubMed ID: 31965258
[TBL] [Abstract][Full Text] [Related]
10. Impact of residual nodal involvement after complete tumor response in patients undergoing neoadjuvant (chemo)radiotherapy for rectal cancer.
Erkan A; Mendez A; Trepanier M; Kelly J; Nassif G; Albert MR; Lee L; Monson JRT
Surgery; 2019 Oct; 166(4):648-654. PubMed ID: 31378480
[TBL] [Abstract][Full Text] [Related]
11. The Role of Adjuvant Chemotherapy after Neoadjuvant Chemoradiotherapy Followed by Surgery in Patients with Esophageal Squamous Cell Carcinoma.
Park SY; Kim HK; Jeon YJ; Lee J; Cho JH; Choi YS; Shim YM; Zo JI
Cancer Res Treat; 2023 Oct; 55(4):1231-1239. PubMed ID: 37114475
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes in patients with ypT0 rectal cancer after neoadjuvant chemoradiotherapy and curative resection.
Lu Z; Cheng P; Yang F; Zheng Z; Wang X
Chin J Cancer Res; 2018 Apr; 30(2):272-281. PubMed ID: 29861612
[TBL] [Abstract][Full Text] [Related]
13. Impact of Extracapsular Lymph Node Involvement After Neoadjuvant Chemoradiation Therapy Followed by Surgery in Carcinoma of the Esophagus: A Multicenter Study.
Depypere LP; Moons J; Mariette C; D'Journo XB; Thomas PA; Hölscher AH; Bollschweiler E; van Berge-Henegouwen MI; Van Lanschot JJB; Lerut TEMR; Nafteux PR
Ann Surg; 2018 Dec; 268(6):1000-1007. PubMed ID: 28742714
[TBL] [Abstract][Full Text] [Related]
14. ypN0: Does It Matter How You Get There? Nodal Downstaging in Esophageal Cancer.
Zanoni A; Verlato G; Giacopuzzi S; Motton M; Casella F; Weindelmayer J; Ambrosi E; Di Leo A; Vassiliadis A; Ricci F; Rice TW; de Manzoni G
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):998-1004. PubMed ID: 27480358
[TBL] [Abstract][Full Text] [Related]
15. Oncologic Outcomes According to Remnant Lymph Node Metastases in Pathologic T0 (ypT0) Esophageal Squamous Cell Carcinoma Following Prospective Neoadjuvant Therapy and Surgery.
Cho HJ; Kim YH; Kim HR; Kim DK; Park SI; Kim JH; Kim SB
Ann Surg Oncol; 2015; 22(6):1851-7. PubMed ID: 25344308
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant Therapy for Locally Advanced Esophageal Cancer Should Be Targeted to Tumor Histology.
Stiles BM; Kamel MK; Harrison SW; Rahouma M; Lee B; Nasar A; Port JL; Altorki NK
Ann Thorac Surg; 2019 Jan; 107(1):187-193. PubMed ID: 30278165
[TBL] [Abstract][Full Text] [Related]
17. Utility of Adjuvant Chemotherapy After Neoadjuvant Chemoradiation and Esophagectomy for Esophageal Cancer.
Burt BM; Groth SS; Sada YH; Farjah F; Cornwell L; Sugarbaker DJ; Massarweh NN
Ann Surg; 2017 Aug; 266(2):297-304. PubMed ID: 27501170
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemoradiation treatment followed by surgery for esophageal cancer: there is much more than the mandard tumor regression score.
Depypere L; Moons J; Lerut T; De Hertogh G; Sagaert X; Coosemans W; Van Veer H; Renders A; Nafteux P
Acta Chir Belg; 2016 Jun; 116(3):149-155. PubMed ID: 27472306
[TBL] [Abstract][Full Text] [Related]
19. Pathologic complete response of primary tumor following preoperative chemoradiotherapy for locally advanced rectal cancer: long-term outcomes and prognostic significance of pathologic nodal status (KROG 09-01).
Yeo SG; Kim DY; Kim TH; Chang HJ; Oh JH; Park W; Choi DH; Nam H; Kim JS; Cho MJ; Kim JH; Park JH; Kang MK; Koom WS; Kim JS; Nam TK; Chie EK; Kim JS; Lee KJ
Ann Surg; 2010 Dec; 252(6):998-1004. PubMed ID: 21107110
[TBL] [Abstract][Full Text] [Related]
20. Lymph node harvest in esophageal cancer after neoadjuvant chemoradiotherapy.
Shridhar R; Hoffe SE; Almhanna K; Weber JM; Chuong MD; Karl RC; Meredith K
Ann Surg Oncol; 2013 Sep; 20(9):3038-43. PubMed ID: 23625142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
